XML 13 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current Assets:    
Cash and cash equivalents $ 27,677,315 $ 204,725
Accounts receivable 47,105 5,110
Other receivable 302,500 302,500
Inventory 24,430 24,430
Prepaid expenses 123,199 170,257
Other current assets 268,966 76,166
Total Current Assets 28,443,515 783,188
Property and Equipment, net of depreciation 1,926,891 2,022,043
Patents, net of amortization 1,997,407 1,991,623
Total Assets 32,367,813 4,796,854
Current Liabilities:    
Accounts payable and accrued expenses 2,676,939 3,509,936
Excise tax payable 1,088,515 964,463
Derivative liabilities 4,771,891 4,772,600
Short-term notes payable 2,003,386 2,647,556
Total Liabilities 10,692,506 11,982,428
Commitments and contingencies (Note 6)
Stockholders’ Equity (Deficit):    
Preferred stock, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value, 300,000,000 shares authorized, 8,512,771 and 7,465,283 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 851 746
Additional paid-in capital 192,365,464 159,027,646
Stock subscription receivable (3,001,045) (2,841,427)
Accumulated deficit (167,689,963) (163,372,539)
Total Stockholders’ Equity (Deficit) 21,675,307 (7,185,574)
Total Liabilities and Stockholders’ Equity (Deficit) 32,367,813 4,796,854
Related Party    
Current Liabilities:    
Due to related party 87,873
Short-term notes payable – related party $ 151,775